- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeffrey Scott on Pharma's Role in Understanding the Value of Novel, Expensive Therapies
Jeffrey A. Scott, MD, chief medical officer, Integra Connect, discusses how pharma can help community oncologists understand the value of novel and expensive therapies.
Jeffrey A. Scott, MD, chief medical officer, Integra Connect, discusses how pharma can help community oncologists understand the value of novel and expensive therapies.
Transcript
How can pharma be leveraged to help community oncologists better understand the value of novel and expensive therapies?
Back in the 80s and 90s, the value to the medical oncologist was the contract, the rebate, the discount. I think those days are going away. I think pharma’s role today in helping me is to support me with the use of real-world data, whether it’s clinical outcomes that occur once a drug is launched, or how does their drug compare in total cost of care versus another drug. Since I don’t always have the 2 new drugs compared head to head, I have to look at other sources of data. So, if I found out that one drug may use less growth factors and have less hospitalization, in the new world order of value-based care, that’s a big win. So, I think pharma needs to build the databases and the stories to support their drugs and the total picture of the care of the patient, not just on the drug side; how it impacts cost across that.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, that has been made in the fight against the HIV pandemic given the current political climate.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
